Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2022-08-31 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 90% confidence The document is very short (311 characters) and contains a table listing a meeting date, analyst/investor name, venue, and type of meeting, which is identified as a 'Conference Call'. There is no detailed transcript or financial data present, only metadata about the meeting. This suggests it is a schedule or summary related to a conference call rather than the full transcript. Since it is not a full transcript, it does not qualify as a Call Transcript (CT). Given the lack of substantive content and the nature of the information, the best fitting category is Regulatory Filings (RNS) as a general announcement or record of the meeting event.
2022-08-31 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation Classification · 85% confidence The document contains a table listing dates, names of analysts or institutional investors, venues, and types of meetings such as one-on-one meetings and conferences. There is no financial data, no report content, no regulatory references, or announcements of filings. The content is consistent with a schedule or summary of investor meetings or presentations. This aligns best with an Investor Presentation (IP) or related investor engagement material. Given the nature of the content as a listing of meetings with investors and analysts, it is most appropriate to classify this as an Investor Presentation (IP). The document is very short and does not contain financial statements or detailed analysis, but it is clearly related to investor communications rather than a regulatory filing or report publication announcement.
2022-08-30 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is very short (343 characters) and contains only a brief summary of bank loan facilities and credit ratings. There is no detailed financial data, no mention of fiscal periods, no regulatory body references, and no indication of a full report. It appears to be a brief rating update or announcement rather than a full financial report or detailed filing. Given the brevity and content, it does not fit into detailed report categories like Annual Report, Interim Report, or Earnings Release. It also does not match categories like Board/Management changes or Legal Proceedings. The best fit is Regulatory Filings (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other categories.
2022-08-29 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 90% confidence The document is extremely short (411 characters) and contains no substantive financial data, analysis, or detailed report content. It appears to be a brief record or schedule of a meeting with an analyst, listing date, analyst name, venue, and meeting type. There is no indication of financial results, regulatory filings, or report publication. This type of content does not fit into detailed report categories like Annual Report, Earnings Release, or Interim Report. It also does not match categories like Board/Management changes or Legal Proceedings. Given the lack of detailed content and the nature of the text, the best fit is Regulatory Filings (RNS) as a general miscellaneous category for brief announcements or notices that do not fit elsewhere.
2022-08-29 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation Classification · 70% confidence The document contains a table listing dates, names of analysts or institutional investors, venues, and types of meetings, specifically one-on-one meetings. There is no indication of financial data, report publication, voting results, or regulatory filings. The content resembles a schedule or record of investor meetings rather than a formal report or announcement. Given the nature of the content, it aligns best with an Investor Presentation (IP) or related investor engagement material. However, since it is a listing of meetings rather than a presentation document, and no other category fits better, the closest classification is Investor Presentation (IP). The document is very short (489 characters) and does not contain financial statements or detailed analysis, but it is related to investor communication.
2022-08-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation Classification · 80% confidence The document contains a table listing dates, names of analysts or institutional investors, venues, and types of meetings such as conference calls and one-on-one meetings. There is no financial data, no report content, no regulatory references, and the document is very short (587 characters). It appears to be a schedule or record of investor meetings rather than a report or announcement. This type of content aligns best with an Investor Presentation (IP) or possibly a Regulatory Filing (RNS) if it were a general announcement. However, since it lists meetings with analysts and investors, it is most consistent with an Investor Presentation or related investor communication. Given the limited content and no actual presentation slides, the best fit is Investor Presentation (IP).
2022-08-17 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.